Medico Remedies Ltd - Prospectus Synopsis

Medico Remedies Ltd RHP

Registered Office : 1105/1106 11-Flr Hubtown Solar , N S Phadke Marg Andheri East , Mumbai - 400069 , Maharashtra , India.

Phone : 91-22-2670 1055/66 Fax :

Email :info@medicoremedies.com Website : www.medicoremedies.com

Public issue of 10,99,200 equity shares of Rs. 10/- each (equity shares) of Medico Remedies Limited (MRL or the company) for cash at a price of Rs. 100 per share (the issue price), aggregating to Rs. 10.99 crores (the issue) consisting of fresh issue of 9,49,200 equity shares aggregating to Rs. 9.49 crores and an offer for sale of 1,50,000 equity shares by the selling shareholders aggregating to Rs. 1.50 crores (offer for sale), of which 57,600 equity shares of Rs. 10 each will be reserved for subscription by market maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. Issue of 10,41,600 equity shares of Rs. 10/- each is hereinafter referred to as the net issue. The issue and the net issue will constitute 26.49% and 25.10% respectively of the post issue paid up equity share capital of the company. The Face value of the equity shares is Rs. 10 and the issue price is 10 times of the face value.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
1/29/2018 12:00:00 AM	1/31/2018 12:00:00 AM	Rs 100 - 0	Rs 0 - 0
Minimum Application for shares in Nos : 1200 Further Multiples of : 1200

	Rs Cr	Lead Managers to the Issue
Project Cost	9.49	Aryaman Financial Services Ltd
Project Financed through Current Offer	10.99
Post Issue Equity Share Capital	9.49
Issue Price	Rs. 100

Projects
Repayment of loans

Promoted By

Listing At

Registrar to the Issue

Haresh Mehta

Harshit Mehta

Rita Mehta

Cameo Corporate Services Ltd

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

Medico Remedies Ltd - Prospectus Synopsis

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.